Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

MYSTERIOUS: Molbio diagnostics - What They Never Told You

Molbio Diagnostics shares rally 30% in 2 days, jump 80% since debut. What lies ahead?

Molbio Diagnostics shares have surged nearly 30% in two sessions, extending their post-listing gains to around 80% from the IPO price. The sharp rally comes as the newly listed company reported a strong Q1 FY27 performance, swinging to a profit of Rs 58.75 crore from a loss in the year-ago…

The Economic Times

Molbio Diagnostics shares rally 6% after strong debut. What should investors do?

Molbio Diagnostics shares rally 6% after strong debut. What should investors do?

Molbio Diagnostics made a strong debut, beating grey market expectations. Experts remain positive on the company’s molecular diagnostics leadership, expansion strategy and industry prospects, though they advise caution after the sharp initial gains and suggest a Rs 900 stop-loss.

The Economic Times

Molbio Diagnostics shares list at 21% premium over IPO price on BSE, NSE

Molbio Diagnostics shares list at 21% premium over IPO price on BSE, NSE

Molbio Diagnostics Share Price: Molbio Diagnostics made a strong stock market debut, listing at a 21.44% premium over its IPO price of Rs 807. The Rs 939.70 crore IPO was subscribed 70.26 times, led by QIBs. The company plans to use IPO proceeds to expand its R&D, manufacturing infrastructure and…

The Economic Times

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Molbio Diagnostics IPO allotment likely today; GMP at 20% — Here’s how to check status

Molbio Diagnostics IPO allotment is expected on Thursday after the Rs 939.70-crore issue was subscribed 70.26 times. With a grey market premium of around 20%, investors await allotment results ahead of the August 17 listing. Proceeds will fund R&D infrastructure, manufacturing expansion and corporate purposes, while FY26 revenue grew 42%…

The Economic Times

Molbio Diagnostics IPO Day 3: GMP hints at 17% listing gain, issue booked nearly 5x. Should you participate?

Molbio Diagnostics IPO: Point-of-care molecular diagnostics company Molbio Diagnostics saw strong investor response for its IPO, drawing as many as 70 times bids overall for its Rs 939 crore issue, with QIBs bidding 180 times the shares on offer.

The Economic Times

Dhoot, Milky Mist or Molbio? What should investors pick in Rs 7,000 crore IPO rush this week

This week, India's IPO market shines brightly as five firms successfully raise over Rs 7,000 crore. Analysts highlight Dhoot Transmission and Molbio Diagnostics as the leading choices for savvy investors. Milky Mist Dairy Food stands out as a reliable option for branded food consumption, while Shiprocket presents an intriguing digital…

The Economic Times

Molbio Diagnostics IPO Day 2: GMP hits at 17% listing gains. Should you bid?

Molbio Diagnostics IPO GMP: The Molbio Diagnostics IPO entered its second day with strong investor interest, as the grey market premium (GMP) climbed to 17% from 15% earlier. The issue was subscribed 83% on Day 1, with retail investors subscribing to 77% of their quota. The Rs 939.70-crore IPO comprises…

The Economic Times

inkl

Read news from The Economist, FT, and more,
with one subscription

Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?

Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?

Molbio Diagnostics IPO GMP: Market analysts have recommended subscribing to the issue, noting that Molbio Diagnostics’ valuations are broadly in line with industry benchmarks. The company is also being offered at a discount to the average P/E multiple of 64.9x for its listed peers, according to analysts.

The Economic Times

World Bank's IFC, HDFC AMC invest in Molbio Diagnostics' Rs 281 crore IPO anchor round

World Bank's IFC, HDFC AMC invest in Molbio Diagnostics' Rs 281 crore IPO anchor round

Molbio Diagnostics raised Rs 281 crore from anchor investors, including World Bank Group's IFC and HDFC Mutual Fund, ahead of its Rs 940 crore IPO opening on August 10. The Goa-based unicorn also saw Rs 160 crore in secondary deals, with major brokerages recommending a Subscribe rating for the issue.

The Economic Times

Rs 7,681 crore IPO rush: Shiprocket, Milky Mist among 9 issues to hit the market

Rs 7,681 crore IPO rush: Shiprocket, Milky Mist among 9 issues to hit the market

India’s primary market is set for a busy week, with nine companies aiming to raise a combined Rs 7,681 crore through IPOs across the mainboard and SME segments. Key issues include Dhoot Transmission, Shiprocket, Milky Mist Dairy Food and Molbio Diagnostics. The IPOs will open between August 10 and 12,…

The Economic Times

Molbio Diagnostics collects Rs 281 cr from anchor investors ahead of IPO

Molbio Diagnostics collects Rs 281 cr from anchor investors ahead of IPO

Molbio Diagnostics has successfully attracted Rs 281.5 crore from anchor investors ahead of its much-anticipated initial public offering. The company aims to raise between Rs 904 crore and Rs 940 crore through this public issue, with funds earmarked for infrastructure improvements and new equipment for manufacturing facilities. Additionally, current shareholders…

The Economic Times

Molbio Diagnostics IPO to open on August 10, price band set at Rs 768-807

Molbio Diagnostics IPO to open on August 10, price band set at Rs 768-807

Molbio Diagnostics is set to launch its IPO on August 10, 2026, with a price band of Rs 768-807 per share. The Rs 939.70 crore public issue comprises a fresh issue of Rs 200 crore and an offer for sale (OFS) of Rs 739.70 crore by existing shareholders. The molecular…

The Economic Times

1

People

Debaroti Adhikary

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

HDFC Mutual Fund

Milky Mist Dairy Food

Dhoot Transmission

Molbio Diagnostics

Behari Lal Engineering

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play